Bristol-Myers Squibb funds independent scientific and clinical research through periodic RFPs focused on advancing knowledge and treatment in prioritized therapeutic areas.
Funder: Bristol-Myers Squibb
Due Dates: June 25, 2026 (Sotyktu RFP #1) | July 16, 2026 (Admilparant RFP #1)
Funding Amounts: Not specified; award size and duration vary by RFP and project scope.
Summary: Supports innovative independent scientific and clinical research through periodic RFP cycles in prioritized therapeutic areas.
Bristol-Myers Squibb (BMS) offers Areas of Interest (AOI) and Competitive Research Grants to fund innovative independent scientific and clinical research aligned with BMS’s current priorities and pipeline assets. The program operates through periodic Request for Proposal (RFP) cycles, each focused on specific therapeutic or disease areas. Researchers are invited to submit research concepts during designated submission windows, with the goal of fostering advancements in science and medicine and addressing unmet medical needs.